Skip to main content
Signal8

Fresenius SE & Co. KGaA (FSNUY)

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Care Facilities

Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA

OTC:FSNUYHealthcare
+0.39%$12.93
Mkt Cap-
Float1.64B
O/S-
Inst Own-
Div Yield2.36%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
SectorHealthcare
IndustryMedical - Care Facilities
ExchangeOTC
CountryDEDE
IPO Date-
Shares Outstanding-
Float1.64B
Company Overview

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care.

It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities.

The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Leadership

Michael Sen

Chief Executive Officer, President & Chairman of Management Board of Fresenius Management SE

Pierluigi Antonelli

Member of Management Board of Fresenius Management SE & Chief Executive Officer of Fresenius Kabi

Sara Hennicken

Chief Financial Officer & Member of the Management Board - Fresenius Management SE

Michael Sven Moser

Member of the Management Board of Fresenius Management SE

Employees

--

Country

DE

Sector

Healthcare

Website

fresenius.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets available
Ratings Distribution
BUY
1
HOLD
0
SELL
0
TOTAL1
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(6)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources: 13F
Insiders & Institutional Holders
52-Week Range
$10.33$33.93
$12.93(11th percentile)
Volume
Average Daily Volume393.06K
97.38K today vs 393.06K avg(-75%)

30d Avg

393.06K

60d Avg

246.22K

90d Avg

209.88K

Earnings
Dividend History
TTM Yield
2.36%
Paid annually
Annual (LTM)
$0.30
Latest
$0.3048
May 26, 26
5Y Growth
+2.69%
per year
Compliance Status
Loading compliance data...